Princess Margaret Hospital researchers identify a key enzyme that affects radiation response

Cancer researchers at Princess Margaret Hospital (PMH) have discovered that targeting an enzyme called Uroporphyrinogen Decarboxylase (UROD) can sensitise diseased tissue to radiation and chemotherapy, which could mean fewer side effects for individuals with head and neck cancer...

Read the whole article on

More from